Rotondo, J.C.; Martini, F.; Maritati, M.; Mazziotta, C.; Di Mauro, G.; Lanzillotti, C.; Barp, N.; Gallerani, A.; Tognon, M.; Contini, C.
SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses 2021, 13, 1687.
https://doi.org/10.3390/v13091687
AMA Style
Rotondo JC, Martini F, Maritati M, Mazziotta C, Di Mauro G, Lanzillotti C, Barp N, Gallerani A, Tognon M, Contini C.
SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses. 2021; 13(9):1687.
https://doi.org/10.3390/v13091687
Chicago/Turabian Style
Rotondo, John Charles, Fernanda Martini, Martina Maritati, Chiara Mazziotta, Giulia Di Mauro, Carmen Lanzillotti, Nicole Barp, Altea Gallerani, Mauro Tognon, and Carlo Contini.
2021. "SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants" Viruses 13, no. 9: 1687.
https://doi.org/10.3390/v13091687
APA Style
Rotondo, J. C., Martini, F., Maritati, M., Mazziotta, C., Di Mauro, G., Lanzillotti, C., Barp, N., Gallerani, A., Tognon, M., & Contini, C.
(2021). SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses, 13(9), 1687.
https://doi.org/10.3390/v13091687
